Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocetirizine Fourfold Dosage in Resistant CSU
NCT02372604Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jul 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of levocetirizine in chronic spontaneous urticaria (CSU) (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Urticaria Activity Score 7 <= 6 at 5 weeks. Started Jul 2015; status: completed.
02
Drugs
levocetirizine
03
Conditions
chronic spontaneous urticaria (CSU)
Beyond the preview
Go deeper on NCT02372604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02372604.